Imaging body fat to save lives.
Adiposs SA
Incorporated
30.01.2020Headquarters
Plan-les-OuatesSupport
Adiposs SA is a clinical-stage, top 100 Swiss life science start-up developing transformative imaging products and technologies.
20 million people get diagnosed with cancer and a staggering 10 million cancer patients die every year. This because 2 out of 3 cancer patients do not respond to therapy. Nobody knows who will respond.
Adiposs is developing the first and only contrast agent for brown fat in cancer patients called ImageBAT®. It is an add-on product to the standard-of-care CT / PET-CT cancer scan available in virtually all hospitals worldwide. ImageBAT® predicts the response to cancer therapy and enables personalised therapy with improved quality of life and survival on a global scale.
News
Adiposs secures CHF 4 Million to advance clinical trials (startupticker.ch)
Adiposs Raises CHF 4M to advance cancer imaging tool (venturelab.swiss)
Kickfund invests at full throttle (startupticker.ch)
Four startups from the medical field obtain the Innosuisse Certificate (startupticker.ch)
Promising breakthroughs in healthcare (startupticker.ch)
The 16 most promising medtech startups in 2022, according to investors (TOP 100)
Good Morning Startups 2022: Credit Suisse investors and TOP 100 startups connect over breakfast (venturelab.swiss)
CHF 1.8 million in first closing of Adiposs pre-Series A equity round (startupticker.ch)
Adiposs raises CHF 1.8 million to start clinical trials and product industrialization (venturelab.swiss)
Venture Leaders Life Sciences and Medtech pitch to an audience of international investors, VCs and experts in Harvard, Cambridge (venturelab.swiss)
Joint roadshow in Boston for Venture Leaders Life Sciences 2020 and Medtech 2021 (venturelab.swiss)
First FIF beneficiaries are Adiposs and ZYTLYN (startupticker.ch)
Green light for Adiposs clinical trials (startupticker.ch)
Ventures for the Virtual Venture Day revealed (startupticker.ch)
Strong Swiss delegation at Bio Europe (startupticker.ch)
CHF 100’000 for early cancer cachexia detection (startupticker.ch)
Meet Venture Leader Andrej Babic and find out which lake inspires great ideas (venturelab.swiss)
Swiss National Startup Team pitched virtually to U.S. investors ahead of life sciences roadshow to Boston (venturelab.swiss)
MassChallenge Switzerland reveals the 2020 cohort (startupticker.ch)
Adiposs and Emovo each receive CHF 150'000 (startupticker.ch)
Milestones news
First subject dosed in IBT-002 imaging efficacy clinical trial
Phase 1 clinical trial completed
Equity round
Winner of Swiss Startup Days 2023 Healthcare Pitching Competition
Closing of Pre-Series A round
Winner of Venture Kick stage 3
Documents
